UK MHRA Prepares To Roll-Out Decentralized Manufacturing Framework

New Guidelines Will Clarify Criteria To Enable Point Of Care And Modular Manufacturing

Gene Therapy for Cancer Treatment Concept Cancer therapy with T-cell and pipette
Decentralized manufacturing allows safe, personalized medicine production near patients (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United Kingdom

More from Compliance